Screening for antisense modulation of dystrophin pre-mRNA splicing (Q34807136)

4 August 2017

1 reference

title

Screening for antisense modulation of dystrophin pre-mRNA splicing (English)

1 reference

4 August 2017

Dickson G

1

1 reference

4 August 2017

Hill V

series ordinal

2

1 reference

4 August 2017

Graham IR

series ordinal

3

1 reference

4 August 2017

publication date

1 October 2002

1 reference

4 August 2017

published in

Neuromuscular Disorders

1 reference

4 August 2017

volume

12 Suppl 1

1 reference

4 August 2017

page(s)

S67-70

1 reference

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Gene transfer to muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Prospects of gene therapy for genetic skeletal muscle disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Gene transfer into canine myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Somatic reversion/suppression of the mouse mdx phenotype in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Intrafamilial variability in dystrophin abundance correlated with difference in the severity of the phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Antisense oligonucleotides in cancer: recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Preclinical and clinical pharmacology of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Modulation of Splicing in theDMDGene by Antisense Oligoribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Selecting effective antisense reagents on combinatorial oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Determining the influence of structure on hybridization using oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Alive with DEAD proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Expression of the murine Duchenne muscular dystrophy gene in muscle and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900085-8

7 January 2021

10.1016/S0960-8966(02)00085-8

Identifiers

DOI

1 reference

4 August 2017

1 reference